Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 16/20 | 0.56 |
| ▸ | CTSB | P07858 | 13/20 | 0.56 |
| ▸ | CTSF | Q9UBX1 | 13/20 | 0.56 |
| ▸ | CTSK | P43235 | 4/20 | 0.39 |
| ▸ | CTSS | P25774 | 3/20 | 0.39 |
| ▸ | CTSV | O60911 | 1/20 | 0.39 |
| ▸ | CTSC | P53634 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3765256 | 0.80 | CTSL (0.85) | CTSLCTSBCTSFCTSKCTSS | |
| SCHEMBL2928196 | 0.75 | CTSL (0.88) | CTSLCTSBCTSFCTSKCTSS | |
| SCHEMBL3804021 | 0.75 | CTSL (0.88) | CTSLCTSBCTSFCTSKCTSS | |
| SCHEMBL3769285 | 0.75 | CTSL (0.88) | CTSLCTSBCTSFCTSKCTSS | |
| SCHEMBL2954991 | 0.72 | CTSL (1.00) | CTSLCTSBCTSFCTSKCTSS | |
| SCHEMBL2927752 | 0.71 | CTSL (0.62) | CTSLCTSBCTSFCTSKCTSS | |
| SCHEMBL3771079 | 0.69 | CTSL (0.78) | CTSLCTSBCTSFCTSKCTSS | |
| SCHEMBL2920244 | 0.69 | CTSL (0.78) | CTSLCTSBCTSFCTSKCTSS | |
| SCHEMBL2927535 | 0.69 | CTSL (0.49) | CTSLCTSBCTSFCTSKCTSS | |
| SCHEMBL2927702 | 0.69 | CTSL (0.83) | CTSLCTSBCTSFCTSKCTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2225196-A1 | CYSTEINE PROTEASE INHIBITORS FOR THE TREATMENT OF PARASITIC DISEASES | Merck Frosst Canada Ltd. (CA) | 2010-09-08 | — | — | EP | disclosed |
| WO-2009067797-A1 | CYSTEINE PROTEASE INHIBITORS FOR THE TREATMENT OF PARASITIC DISEASES | MERCK FROSST CANADA LTD. (CA) | 2009-06-04 | — | — | WO | disclosed |